Precision Biosciences Inc. (DTIL) NASDAQ
$10.77 (0.74) (-6.43%)
Market Cap: $79.61M
As of 04/18/24 03:59 PM EDT. Market closed.
Precision Biosciences Inc. (DTIL)
NASDAQ
$10.77
(0.74) (-6.43%)
Market Cap: $79.61M
As of 04/18/24 03:59 PM EDT. Market closed.
Add to Portfolio
precision biosciences, inc. is a biotechnology company located in durham, north carolina, united ... read more
precision biosciences, inc. is a biotechnology company located in durham, north carolina, united states. read less
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
CEO
Matthew Kane
Full Time Employees
218
CEO Compensation (Base)
$350,000
CEO Compensation (Total)
$1.59M
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
CEO
Matthew Kane
Full Time Employees
218
CEO Compensation (Base)
$350,000
CEO Compensation (Total)
$1.59M
Address
302 E Pettigrew St Ste A100, North Carolina, Durham, 27701-2393.
PRICE CHART FOR PRECISION BIOSCIENCES INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$11.41
Previous Close
$11.51
Days Range
$11.16 - $12
52 week range
$8.25 - $27.90
Volume
71,899
Avg. Volume (30 days)
146,018
Market Cap
$79.61M
Dividend Yield
-
P/E
(1.30)
Shares Outstanding
6,916,239
Open
$11.41
Previous Close
$11.51
Days Range
$11.16 - $12
52 week range
$8.25 - $27.90
Volume
71,899
Avg. Volume (30 days)
146,018
Market Cap
$79.61M
Dividend Yield
-
P/E
(1.30)
Shares Outstanding
6,916,239
FINANCIAL STATEMENTS FOR PRECISION BIOSCIENCES INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR PRECISION BIOSCIENCES INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Amoroso Michael | President and CEO | Jan 22, 2024 | Sale | $0.36 | 137,390 | 49,460 | 356,433 | Jan 23, 2024, 07:17 PM |
| Scimeca Dario | General Counsel and Secretary | Jan 22, 2024 | Sale | $0.36 | 21,287 | 7,663 | 151,028 | Jan 23, 2024, 07:15 PM |
| List Alan | Chief Medical Officer | Jan 22, 2024 | Sale | $0.36 | 21,526 | 7,749 | 94,982 | Jan 23, 2024, 07:13 PM |
| SMITH J. JEFFERSON | Chief Research Officer | Jan 23, 2024 | Sale | $0.37 | 28,000 | 10,360 | 1,987,269 | Jan 23, 2024, 07:11 PM |
| Scimeca Dario | General Counsel and Secretary | Nov 03, 2023 | Sale | $0.40 | 16,023 | 6,409 | 112,970 | Nov 06, 2023, 05:09 PM |
| Amoroso Michael | President and CEO | Nov 03, 2023 | Sale | $0.40 | 125,025 | 50,010 | 227,103 | Nov 06, 2023, 05:07 PM |
| Kelly John Alexander | Chief Financial Officer | Aug 18, 2023 | Buy | $0.48 | 90,000 | 43,200 | 383,340 | Oct 27, 2023, 04:55 PM |
| Scimeca Dario | General Counsel and Secretary | Aug 31, 2023 | Option Exercise | $0.39 | 5,443 | 2,123 | 73,916 | Sep 05, 2023, 04:16 PM |
| SMITH J. JEFFERSON | Chief Research Officer | Aug 31, 2023 | Option Exercise | $0.39 | 5,175 | 2,018 | 1,940,254 | Sep 05, 2023, 04:15 PM |
| Kelly John Alexander | Chief Financial Officer | Aug 31, 2023 | Option Exercise | $0.39 | 5,951 | 2,321 | 389,291 | Sep 05, 2023, 04:15 PM |
| Kelly John Alexander | Chief Financial Officer | Aug 18, 2023 | Option Exercise | $0.48 | 90,000 | 43,200 | 383,340 | Aug 22, 2023, 04:10 PM |
| Scimeca Dario | General Counsel and Secretary | Jun 08, 2023 | Sale | $0.75 | 13,361 | 10,021 | 68,473 | Jun 09, 2023, 04:15 PM |
| List Alan | Chief Medical Officer | Apr 27, 2023 | Sale | $0.79 | 7,771 | 6,139 | 56,496 | Apr 28, 2023, 04:53 PM |
| Amoroso Michael | President and CEO | Mar 22, 2023 | Sale | $0.82 | 46,999 | 38,539 | 68,738 | Mar 23, 2023, 04:00 PM |
| Kelly John Alexander | Chief Financial Officer | Mar 17, 2023 | Buy | $0.86 | 20,000 | 17,200 | 245,614 | Mar 21, 2023, 09:19 AM |
| Scimeca Dario | General Counsel and Secretary | Feb 28, 2023 | Option Exercise | $0.95 | 2,163 | 2,055 | 34,677 | Mar 07, 2023, 05:19 PM |
| Scimeca Dario | General Counsel and Secretary | Mar 06, 2023 | Sale | $1.07 | 12,172 | 13,024 | 50,063 | Mar 07, 2023, 05:19 PM |
| List Alan | Chief Medical Officer | Mar 06, 2023 | Sale | $1.07 | 9,473 | 10,136 | 38,240 | Mar 07, 2023, 05:16 PM |
| SMITH J. JEFFERSON | Chief Research Officer | Feb 28, 2023 | Option Exercise | $0.95 | 12,157 | 11,549 | 1,914,631 | Mar 07, 2023, 05:12 PM |
| Kelly John Alexander | Chief Financial Officer | Feb 28, 2023 | Option Exercise | $0.95 | 11,605 | 11,025 | 174,543 | Mar 07, 2023, 05:08 PM |
| Amoroso Michael | President and CEO | Oct 17, 2022 | Sale | $1.32 | 11,006 | 14,528 | 13,202 | Oct 18, 2022, 04:13 PM |
| Kelly John Alexander | Chief Financial Officer | Sep 23, 2022 | Buy | $1.23 | 8,200 | 10,086 | 162,938 | Sep 26, 2022, 04:10 PM |
| Kelly John Alexander | Chief Financial Officer | Sep 22, 2022 | Buy | $1.34 | 37,037 | 49,630 | 154,738 | Sep 26, 2022, 04:10 PM |
| Kelly John Alexander | Chief Financial Officer | Jun 22, 2022 | Buy | $1.50 | 33,784 | 50,676 | 117,701 | Jun 24, 2022, 08:59 AM |
| JANTZ DEREK | Chief Scientific Officer | Jun 08, 2022 | Sale | $2.06 | 18,849 | 38,829 | 4,055,174 | Jun 09, 2022, 04:42 PM |
| Scimeca Dario | General Counsel and Secretary | Jun 08, 2022 | Sale | $2.06 | 9,833 | 20,256 | 32,514 | Jun 09, 2022, 04:36 PM |
| List Alan | Chief Medical Officer | Apr 27, 2022 | Sale | $2.10 | 7,775 | 16,327 | 18,260 | Apr 28, 2022, 05:22 PM |
| Kelly John Alexander | Chief Financial Officer | Mar 17, 2022 | Buy | $3.08 | 16,677 | 51,365 | 36,189 | Mar 21, 2022, 06:22 PM |
| Barton Shane | VP & Corporate Controller | Feb 28, 2022 | Option Exercise | $3.61 | 761 | 2,747 | 2,659 | Mar 07, 2022, 04:22 PM |
| Barton Shane | VP & Corporate Controller | Aug 31, 2021 | Option Exercise | $10.68 | 604 | 6,451 | 1,898 | Mar 07, 2022, 04:22 PM |
| Barton Shane | VP & Corporate Controller | Feb 26, 2021 | Option Exercise | $4.61 | 1,294 | 5,965 | 1,294 | Mar 07, 2022, 04:22 PM |
| Scimeca Dario | General Counsel and Secretary | Feb 26, 2021 | Option Exercise | $4.61 | 2,748 | 12,668 | 7,976 | Mar 07, 2022, 04:14 PM |
| Scimeca Dario | General Counsel and Secretary | Aug 31, 2020 | Option Exercise | $4.79 | 3,156 | 15,117 | 5,228 | Mar 07, 2022, 04:14 PM |
| Scimeca Dario | General Counsel and Secretary | Feb 28, 2020 | Option Exercise | $5.61 | 2,072 | 11,624 | 2,072 | Mar 07, 2022, 04:14 PM |
| Scimeca Dario | General Counsel and Secretary | Feb 28, 2022 | Option Exercise | $3.61 | 2,049 | 7,397 | 10,573 | Mar 07, 2022, 04:14 PM |
| Scimeca Dario | General Counsel and Secretary | Aug 31, 2021 | Option Exercise | $10.68 | 548 | 5,853 | 8,524 | Mar 07, 2022, 04:14 PM |
| Kelly John Alexander | Chief Financial Officer | Feb 28, 2022 | Option Exercise | $3.61 | 2,714 | 9,798 | 19,512 | Mar 07, 2022, 04:08 PM |
| Kelly John Alexander | Chief Financial Officer | Aug 31, 2021 | Option Exercise | $10.68 | 998 | 10,659 | 16,798 | Mar 07, 2022, 04:08 PM |
| THOMSON DAVID S. | Chief Operating Officer | Jun 21, 2021 | Option Exercise | $1.18 | 15,000 | 17,700 | 126,513 | Jun 23, 2021, 07:24 PM |
| THOMSON DAVID S. | Chief Operating Officer | Jun 21, 2021 | Sale | $10.77 | 15,000 | 161,550 | 111,513 | Jun 23, 2021, 07:24 PM |
| THOMSON DAVID S. | Chief Operating Officer | Jun 18, 2021 | Option Exercise | $1.18 | 10,000 | 11,800 | 121,513 | Jun 21, 2021, 04:23 PM |
| THOMSON DAVID S. | Chief Operating Officer | Jun 17, 2021 | Option Exercise | $1.18 | 10,000 | 11,800 | 121,513 | Jun 21, 2021, 04:23 PM |
| THOMSON DAVID S. | Chief Operating Officer | Jun 18, 2021 | Sale | $11.00 | 10,000 | 110,000 | 111,513 | Jun 21, 2021, 04:23 PM |
| THOMSON DAVID S. | Chief Operating Officer | Jun 17, 2021 | Sale | $10.44 | 10,000 | 104,400 | 111,513 | Jun 21, 2021, 04:23 PM |
| THOMSON DAVID S. | Chief Operating Officer | Jun 11, 2021 | Option Exercise | $1.18 | 30,000 | 35,400 | 141,513 | Jun 15, 2021, 04:19 PM |
| THOMSON DAVID S. | Chief Operating Officer | Jun 11, 2021 | Sale | $11.52 | 30,000 | 345,600 | 111,513 | Jun 15, 2021, 04:19 PM |
| JANTZ DEREK | Chief Scientific Officer | May 17, 2021 | Sale | $9.38 | 20,000 | 187,600 | 4,032,279 | May 19, 2021, 08:44 AM |
| JANTZ DEREK | Chief Scientific Officer | May 14, 2021 | Option Exercise | $0.04 | 21,514 | 861 | 4,061,952 | May 18, 2021, 04:25 PM |
| JANTZ DEREK | Chief Scientific Officer | May 14, 2021 | Sale | $9.17 | 9,673 | 88,701 | 4,052,279 | May 18, 2021, 04:25 PM |
| KANE MATTHEW R. | President and CEO | Apr 21, 2021 | Option Exercise | $1.18 | 13,422 | 15,838 | 1,978,218 | Apr 23, 2021, 04:06 PM |
| JANTZ DEREK | Chief Scientific Officer | Apr 19, 2021 | Option Exercise | $0.04 | 21,514 | 861 | 4,026,435 | Apr 21, 2021, 04:11 PM |
| JANTZ DEREK | Chief Scientific Officer | Apr 19, 2021 | Sale | $8.69 | 9,676 | 84,084 | 4,016,759 | Apr 21, 2021, 04:11 PM |
| JANTZ DEREK | Chief Scientific Officer | Apr 16, 2021 | Option Exercise | $0.04 | 21,514 | 861 | 4,014,596 | Apr 19, 2021, 04:06 PM |
| JANTZ DEREK | Chief Scientific Officer | Apr 15, 2021 | Option Exercise | $0.04 | 21,514 | 861 | 4,002,758 | Apr 19, 2021, 04:06 PM |
| JANTZ DEREK | Chief Scientific Officer | Apr 15, 2021 | Sale | $8.76 | 9,676 | 84,762 | 3,993,082 | Apr 19, 2021, 04:06 PM |
| JANTZ DEREK | Chief Scientific Officer | Apr 16, 2021 | Sale | $8.84 | 9,675 | 85,527 | 4,004,921 | Apr 19, 2021, 04:06 PM |
| KANE MATTHEW R. | President and CEO | Apr 12, 2021 | Option Exercise | $0.04 | 21,514 | 861 | 1,974,537 | Apr 14, 2021, 04:37 PM |
| KANE MATTHEW R. | President and CEO | Apr 12, 2021 | Sale | $8.67 | 9,741 | 84,454 | 1,964,796 | Apr 14, 2021, 04:37 PM |
| KANE MATTHEW R. | President and CEO | Apr 09, 2021 | Option Exercise | $0.04 | 21,514 | 861 | 1,962,760 | Apr 12, 2021, 05:06 PM |
| KANE MATTHEW R. | President and CEO | Apr 08, 2021 | Option Exercise | $0.04 | 21,514 | 861 | 1,950,982 | Apr 12, 2021, 05:06 PM |
| KANE MATTHEW R. | President and CEO | Apr 08, 2021 | Sale | $9.00 | 9,736 | 87,624 | 1,941,246 | Apr 12, 2021, 05:06 PM |
| KANE MATTHEW R. | President and CEO | Apr 09, 2021 | Sale | $8.87 | 9,737 | 86,367 | 1,953,023 | Apr 12, 2021, 05:06 PM |
| JANTZ DEREK | Chief Scientific Officer | Mar 18, 2021 | Option Exercise | $0.04 | 21,514 | 861 | 3,990,909 | Mar 22, 2021, 04:12 PM |
| JANTZ DEREK | Chief Scientific Officer | Mar 18, 2021 | Sale | $11.08 | 9,665 | 107,088 | 3,981,244 | Mar 22, 2021, 04:12 PM |
| JANTZ DEREK | Chief Scientific Officer | Mar 17, 2021 | Option Exercise | $0.04 | 21,514 | 861 | 3,979,060 | Mar 18, 2021, 04:05 PM |
| JANTZ DEREK | Chief Scientific Officer | Mar 16, 2021 | Option Exercise | $0.04 | 21,514 | 861 | 3,967,207 | Mar 18, 2021, 04:05 PM |
| JANTZ DEREK | Chief Scientific Officer | Mar 16, 2021 | Sale | $11.97 | 9,661 | 115,642 | 3,957,546 | Mar 18, 2021, 04:05 PM |
| JANTZ DEREK | Chief Scientific Officer | Mar 17, 2021 | Sale | $10.92 | 9,665 | 105,542 | 3,969,395 | Mar 18, 2021, 04:05 PM |
| KANE MATTHEW R. | President and CEO | Mar 12, 2021 | Option Exercise | $0.04 | 21,514 | 861 | 1,939,180 | Mar 16, 2021, 04:34 PM |
| KANE MATTHEW R. | President and CEO | Mar 12, 2021 | Sale | $11.36 | 9,712 | 110,328 | 1,929,468 | Mar 16, 2021, 04:34 PM |
| KANE MATTHEW R. | President and CEO | Mar 10, 2021 | Option Exercise | $0.04 | 21,514 | 861 | 1,915,573 | Mar 12, 2021, 06:03 PM |
| KANE MATTHEW R. | President and CEO | Mar 11, 2021 | Option Exercise | $0.04 | 21,514 | 861 | 1,927,377 | Mar 12, 2021, 06:03 PM |
| KANE MATTHEW R. | President and CEO | Mar 10, 2021 | Sale | $11.79 | 9,710 | 114,481 | 1,905,863 | Mar 12, 2021, 06:03 PM |
| KANE MATTHEW R. | President and CEO | Mar 11, 2021 | Sale | $11.38 | 9,711 | 110,511 | 1,917,666 | Mar 12, 2021, 06:03 PM |
| JANTZ DEREK | Chief Scientific Officer | Feb 22, 2021 | Option Exercise | $0.04 | 21,514 | 861 | 3,955,353 | Feb 24, 2021, 05:46 PM |
| JANTZ DEREK | Chief Scientific Officer | Feb 22, 2021 | Sale | $12.04 | 9,660 | 116,306 | 3,945,693 | Feb 24, 2021, 05:46 PM |
| JANTZ DEREK | Chief Scientific Officer | Feb 18, 2021 | Option Exercise | $0.04 | 21,514 | 861 | 3,928,859 | Feb 22, 2021, 07:03 PM |
| JANTZ DEREK | Chief Scientific Officer | Feb 19, 2021 | Option Exercise | $0.04 | 21,514 | 861 | 3,943,502 | Feb 22, 2021, 07:03 PM |
| JANTZ DEREK | Chief Scientific Officer | Feb 18, 2021 | Sale | $12.20 | 6,871 | 83,826 | 3,921,988 | Feb 22, 2021, 07:03 PM |
| JANTZ DEREK | Chief Scientific Officer | Feb 19, 2021 | Sale | $11.55 | 9,663 | 111,608 | 3,933,839 | Feb 22, 2021, 07:03 PM |
| KANE MATTHEW R. | President and CEO | Feb 18, 2021 | Option Exercise | $0.04 | 21,514 | 861 | 1,899,151 | Feb 22, 2021, 04:45 PM |
| KANE MATTHEW R. | President and CEO | Feb 18, 2021 | Sale | $12.23 | 9,705 | 118,692 | 1,889,446 | Feb 22, 2021, 04:45 PM |
| KANE MATTHEW R. | President and CEO | Feb 16, 2021 | Option Exercise | $0.04 | 21,514 | 861 | 1,875,525 | Feb 18, 2021, 04:44 PM |
| KANE MATTHEW R. | President and CEO | Feb 17, 2021 | Option Exercise | $0.04 | 21,514 | 861 | 1,887,342 | Feb 18, 2021, 04:44 PM |
| KANE MATTHEW R. | President and CEO | Feb 17, 2021 | Sale | $12.28 | 9,705 | 119,177 | 1,877,637 | Feb 18, 2021, 04:44 PM |
| KANE MATTHEW R. | President and CEO | Feb 16, 2021 | Sale | $13.30 | 9,697 | 128,970 | 1,865,828 | Feb 18, 2021, 04:44 PM |
| JANTZ DEREK | Chief Scientific Officer | Jan 29, 2021 | Option Exercise | $0.04 | 21,515 | 861 | 3,913,789 | Feb 02, 2021, 05:00 PM |
| JANTZ DEREK | Chief Scientific Officer | Jan 29, 2021 | Sale | $12.25 | 6,444 | 78,939 | 3,907,345 | Feb 02, 2021, 05:00 PM |
| JANTZ DEREK | Chief Scientific Officer | Jan 27, 2021 | Option Exercise | $0.04 | 21,514 | 861 | 3,884,252 | Jan 29, 2021, 05:00 PM |
| JANTZ DEREK | Chief Scientific Officer | Jan 28, 2021 | Option Exercise | $0.04 | 21,514 | 861 | 3,898,718 | Jan 29, 2021, 05:00 PM |
| JANTZ DEREK | Chief Scientific Officer | Jan 28, 2021 | Sale | $11.97 | 6,444 | 77,135 | 3,892,274 | Jan 29, 2021, 05:00 PM |
| JANTZ DEREK | Chief Scientific Officer | Jan 27, 2021 | Sale | $11.68 | 7,048 | 82,321 | 3,877,204 | Jan 29, 2021, 05:00 PM |
| KANE MATTHEW R. | President and CEO | Jan 26, 2021 | Option Exercise | $0.04 | 21,515 | 861 | 1,863,708 | Jan 28, 2021, 04:00 PM |
| KANE MATTHEW R. | President and CEO | Jan 26, 2021 | Sale | $13.37 | 9,697 | 129,649 | 1,854,011 | Jan 28, 2021, 04:00 PM |
| KANE MATTHEW R. | President and CEO | Jan 22, 2021 | Option Exercise | $0.04 | 21,514 | 861 | 1,840,592 | Jan 26, 2021, 04:56 PM |
| KANE MATTHEW R. | President and CEO | Jan 25, 2021 | Option Exercise | $0.04 | 21,514 | 861 | 1,851,888 | Jan 26, 2021, 04:56 PM |
| KANE MATTHEW R. | President and CEO | Jan 25, 2021 | Sale | $13.74 | 9,695 | 133,209 | 1,842,193 | Jan 26, 2021, 04:56 PM |
| KANE MATTHEW R. | President and CEO | Jan 22, 2021 | Sale | $13.53 | 10,218 | 138,250 | 1,830,374 | Jan 26, 2021, 04:56 PM |
| THOMSON DAVID S. | Chief Operating Officer | Jan 21, 2021 | Sale | $16.49 | 10,000 | 164,900 | 109,243 | Jan 25, 2021, 08:00 AM |
| ANSARI ABID | Chief Financial Officer | Jun 15, 2020 | Option Exercise | $1.20 | 8,783 | 10,540 | 144,401 | Jun 17, 2020, 04:00 PM |
| ANSARI ABID | Chief Financial Officer | May 15, 2020 | Option Exercise | $1.20 | 9,661 | 11,576 | 135,618 | May 19, 2020, 07:17 AM |
| JANTZ DEREK | Chief Scientific Officer | Apr 14, 2020 | Option Exercise | $1.18 | 4,392 | 5,183 | 3,862,738 | Apr 15, 2020, 05:26 PM |
| ANSARI ABID | Chief Financial Officer | Jan 06, 2020 | Option Exercise | $1.20 | 20,200 | 24,187 | 123,845 | Jan 08, 2020, 08:23 AM |
| Heery Christopher | Chief Medical Officer | Dec 19, 2019 | Buy | $12.08 | 2,485 | 30,021 | 2,485 | Dec 20, 2019, 04:44 PM |
| KANE MATTHEW R. | President and CEO | Sep 23, 2019 | Option Exercise | $1.18 | 10,000 | 11,800 | 1,812,427 | Sep 25, 2019, 04:23 PM |
| JANTZ DEREK | Chief Scientific Officer | Sep 10, 2019 | Option Exercise | $1.18 | 13,176 | 15,548 | 3,858,346 | Sep 12, 2019, 10:47 AM |
| ANSARI ABID | Chief Financial Officer | Jun 10, 2019 | Option Exercise | $1.20 | 103,645 | 124,233 | 103,645 | Jun 12, 2019, 10:27 AM |
| THOMSON DAVID S. | Chief Development Officer | Jun 10, 2019 | Option Exercise | $1.18 | 117,113 | 138,193 | 117,113 | Jun 12, 2019, 10:26 AM |
| YAO TONY DUNG LING | Director | Apr 03, 2019 | Buy | $15.42 | 6,487 | 100,030 | 158,003 | Apr 04, 2019, 05:00 PM |
| FMR LLC | See Remark 1 | Apr 01, 2019 | Buy | $16.00 | 50,000 | 800,000 | 3,738,248 | Apr 03, 2019, 05:07 PM |
| YAO TONY DUNG LING | Director | Apr 01, 2019 | Option Exercise | $13.60 | 36,946 | 502,466 | 36,946 | Apr 02, 2019, 05:19 PM |
| Schinazi Raymond F | Director | Apr 01, 2019 | Option Exercise | $13.60 | 36,946 | 502,466 | 36,946 | Apr 02, 2019, 05:19 PM |
| venBio Global Strategic Fund, L.P. | Director | Apr 01, 2019 | Buy | $16.00 | 50,000 | 800,000 | 50,000 | Apr 01, 2019, 05:35 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Amoroso Michael | President and CEO | 01/22/2024 | 49,460 |
| Scimeca Dario | General Counsel and Secretary | 01/22/2024 | 7,663 |
| List Alan | Chief Medical Officer | 01/22/2024 | 7,749 |
| SMITH J. JEFFERSON | Chief Research Officer | 01/23/2024 | 10,360 |
| Scimeca Dario | General Counsel and Secretary | 11/03/2023 | 6,409 |
| Amoroso Michael | President and CEO | 11/03/2023 | 50,010 |
| Kelly John Alexander | Chief Financial Officer | 08/18/2023 | 43,200 |
| Scimeca Dario | General Counsel and Secretary | 08/31/2023 | 2,123 |
| SMITH J. JEFFERSON | Chief Research Officer | 08/31/2023 | 2,018 |
| Kelly John Alexander | Chief Financial Officer | 08/31/2023 | 2,321 |
| Kelly John Alexander | Chief Financial Officer | 08/18/2023 | 43,200 |
| Scimeca Dario | General Counsel and Secretary | 06/08/2023 | 10,021 |
| List Alan | Chief Medical Officer | 04/27/2023 | 6,139 |
| Amoroso Michael | President and CEO | 03/22/2023 | 38,539 |
| Kelly John Alexander | Chief Financial Officer | 03/17/2023 | 17,200 |
| Scimeca Dario | General Counsel and Secretary | 02/28/2023 | 2,055 |
| Scimeca Dario | General Counsel and Secretary | 03/06/2023 | 13,024 |
| List Alan | Chief Medical Officer | 03/06/2023 | 10,136 |
| SMITH J. JEFFERSON | Chief Research Officer | 02/28/2023 | 11,549 |
| Kelly John Alexander | Chief Financial Officer | 02/28/2023 | 11,025 |
| Amoroso Michael | President and CEO | 10/17/2022 | 14,528 |
| Kelly John Alexander | Chief Financial Officer | 09/23/2022 | 10,086 |
| Kelly John Alexander | Chief Financial Officer | 09/22/2022 | 49,630 |
| Kelly John Alexander | Chief Financial Officer | 06/22/2022 | 50,676 |
| JANTZ DEREK | Chief Scientific Officer | 06/08/2022 | 38,829 |
| Scimeca Dario | General Counsel and Secretary | 06/08/2022 | 20,256 |
| List Alan | Chief Medical Officer | 04/27/2022 | 16,327 |
| Kelly John Alexander | Chief Financial Officer | 03/17/2022 | 51,365 |
| Barton Shane | VP & Corporate Controller | 02/28/2022 | 2,747 |
| Barton Shane | VP & Corporate Controller | 08/31/2021 | 6,451 |
| Barton Shane | VP & Corporate Controller | 02/26/2021 | 5,965 |
| Scimeca Dario | General Counsel and Secretary | 02/26/2021 | 12,668 |
| Scimeca Dario | General Counsel and Secretary | 08/31/2020 | 15,117 |
| Scimeca Dario | General Counsel and Secretary | 02/28/2020 | 11,624 |
| Scimeca Dario | General Counsel and Secretary | 02/28/2022 | 7,397 |
| Scimeca Dario | General Counsel and Secretary | 08/31/2021 | 5,853 |
| Kelly John Alexander | Chief Financial Officer | 02/28/2022 | 9,798 |
| Kelly John Alexander | Chief Financial Officer | 08/31/2021 | 10,659 |
| THOMSON DAVID S. | Chief Operating Officer | 06/21/2021 | 17,700 |
| THOMSON DAVID S. | Chief Operating Officer | 06/21/2021 | 161,550 |
| THOMSON DAVID S. | Chief Operating Officer | 06/18/2021 | 11,800 |
| THOMSON DAVID S. | Chief Operating Officer | 06/17/2021 | 11,800 |
| THOMSON DAVID S. | Chief Operating Officer | 06/18/2021 | 110,000 |
| THOMSON DAVID S. | Chief Operating Officer | 06/17/2021 | 104,400 |
| THOMSON DAVID S. | Chief Operating Officer | 06/11/2021 | 35,400 |
| THOMSON DAVID S. | Chief Operating Officer | 06/11/2021 | 345,600 |
| JANTZ DEREK | Chief Scientific Officer | 05/17/2021 | 187,600 |
| JANTZ DEREK | Chief Scientific Officer | 05/14/2021 | 861 |
| JANTZ DEREK | Chief Scientific Officer | 05/14/2021 | 88,701 |
| KANE MATTHEW R. | President and CEO | 04/21/2021 | 15,838 |
| JANTZ DEREK | Chief Scientific Officer | 04/19/2021 | 861 |
| JANTZ DEREK | Chief Scientific Officer | 04/19/2021 | 84,084 |
| JANTZ DEREK | Chief Scientific Officer | 04/16/2021 | 861 |
| JANTZ DEREK | Chief Scientific Officer | 04/15/2021 | 861 |
| JANTZ DEREK | Chief Scientific Officer | 04/15/2021 | 84,762 |
| JANTZ DEREK | Chief Scientific Officer | 04/16/2021 | 85,527 |
| KANE MATTHEW R. | President and CEO | 04/12/2021 | 861 |
| KANE MATTHEW R. | President and CEO | 04/12/2021 | 84,454 |
| KANE MATTHEW R. | President and CEO | 04/09/2021 | 861 |
| KANE MATTHEW R. | President and CEO | 04/08/2021 | 861 |
| KANE MATTHEW R. | President and CEO | 04/08/2021 | 87,624 |
| KANE MATTHEW R. | President and CEO | 04/09/2021 | 86,367 |
| JANTZ DEREK | Chief Scientific Officer | 03/18/2021 | 861 |
| JANTZ DEREK | Chief Scientific Officer | 03/18/2021 | 107,088 |
| JANTZ DEREK | Chief Scientific Officer | 03/17/2021 | 861 |
| JANTZ DEREK | Chief Scientific Officer | 03/16/2021 | 861 |
| JANTZ DEREK | Chief Scientific Officer | 03/16/2021 | 115,642 |
| JANTZ DEREK | Chief Scientific Officer | 03/17/2021 | 105,542 |
| KANE MATTHEW R. | President and CEO | 03/12/2021 | 861 |
| KANE MATTHEW R. | President and CEO | 03/12/2021 | 110,328 |
| KANE MATTHEW R. | President and CEO | 03/10/2021 | 861 |
| KANE MATTHEW R. | President and CEO | 03/11/2021 | 861 |
| KANE MATTHEW R. | President and CEO | 03/10/2021 | 114,481 |
| KANE MATTHEW R. | President and CEO | 03/11/2021 | 110,511 |
| JANTZ DEREK | Chief Scientific Officer | 02/22/2021 | 861 |
| JANTZ DEREK | Chief Scientific Officer | 02/22/2021 | 116,306 |
| JANTZ DEREK | Chief Scientific Officer | 02/18/2021 | 861 |
| JANTZ DEREK | Chief Scientific Officer | 02/19/2021 | 861 |
| JANTZ DEREK | Chief Scientific Officer | 02/18/2021 | 83,826 |
| JANTZ DEREK | Chief Scientific Officer | 02/19/2021 | 111,608 |
| KANE MATTHEW R. | President and CEO | 02/18/2021 | 861 |
| KANE MATTHEW R. | President and CEO | 02/18/2021 | 118,692 |
| KANE MATTHEW R. | President and CEO | 02/16/2021 | 861 |
| KANE MATTHEW R. | President and CEO | 02/17/2021 | 861 |
| KANE MATTHEW R. | President and CEO | 02/17/2021 | 119,177 |
| KANE MATTHEW R. | President and CEO | 02/16/2021 | 128,970 |
| JANTZ DEREK | Chief Scientific Officer | 01/29/2021 | 861 |
| JANTZ DEREK | Chief Scientific Officer | 01/29/2021 | 78,939 |
| JANTZ DEREK | Chief Scientific Officer | 01/27/2021 | 861 |
| JANTZ DEREK | Chief Scientific Officer | 01/28/2021 | 861 |
| JANTZ DEREK | Chief Scientific Officer | 01/28/2021 | 77,135 |
| JANTZ DEREK | Chief Scientific Officer | 01/27/2021 | 82,321 |
| KANE MATTHEW R. | President and CEO | 01/26/2021 | 861 |
| KANE MATTHEW R. | President and CEO | 01/26/2021 | 129,649 |
| KANE MATTHEW R. | President and CEO | 01/22/2021 | 861 |
| KANE MATTHEW R. | President and CEO | 01/25/2021 | 861 |
| KANE MATTHEW R. | President and CEO | 01/25/2021 | 133,209 |
| KANE MATTHEW R. | President and CEO | 01/22/2021 | 138,250 |
| THOMSON DAVID S. | Chief Operating Officer | 01/21/2021 | 164,900 |
| ANSARI ABID | Chief Financial Officer | 06/15/2020 | 10,540 |
| ANSARI ABID | Chief Financial Officer | 05/15/2020 | 11,576 |
| JANTZ DEREK | Chief Scientific Officer | 04/14/2020 | 5,183 |
| ANSARI ABID | Chief Financial Officer | 01/06/2020 | 24,187 |
| Heery Christopher | Chief Medical Officer | 12/19/2019 | 30,021 |
| KANE MATTHEW R. | President and CEO | 09/23/2019 | 11,800 |
| JANTZ DEREK | Chief Scientific Officer | 09/10/2019 | 15,548 |
| ANSARI ABID | Chief Financial Officer | 06/10/2019 | 124,233 |
| THOMSON DAVID S. | Chief Development Officer | 06/10/2019 | 138,193 |
| YAO TONY DUNG LING | Director | 04/03/2019 | 100,030 |
| FMR LLC | See Remark 1 | 04/01/2019 | 800,000 |
| YAO TONY DUNG LING | Director | 04/01/2019 | 502,466 |
| Schinazi Raymond F | Director | 04/01/2019 | 502,466 |
| venBio Global Strategic Fund, L.P. | Director | 04/01/2019 | 800,000 |
Load More Insider Transactions
FUNDS WITH A POSITION IN PRECISION BIOSCIENCES INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| CAPITAL WORLD INVESTORS | 5,119,458 | 0.00033% | -23.76% | Growth At A Reasonable Price |
| RENAISSANCE TECHNOLOGIES LLC | 2,591,212 | 0.00146% | 62.76% | Other |
| BLACKROCK INC. | 1,118,967 | 0.00001% | No change | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 895,415 | 0.00003% | 10.16% | Other |
| UBS OCONNOR LLC | 238,105 | 0.00625% | -82.21% | Value |
| VIVO CAPITAL, LLC | 140,255 | 0.00419% | No change | Other |
BUYBACK ANNOUNCEMENT(S) FOR PRECISION BIOSCIENCES INC
LOADING...